|
| Entrez Id: |
406953 |
| Gene Symbol: |
MIR18A |
MIR18A
|
Liver neoplasms
|
0.200 |
ModifyingMutation |
RGD |
A novel SOCS5/miR-18/miR-25 axis promotes tumorigenesis in liver cancer.
|
30191950 |
2019 |
|
| Entrez Id: |
407014 |
| Gene Symbol: |
MIR25 |
MIR25
|
Liver neoplasms
|
0.200 |
ModifyingMutation |
RGD |
A novel SOCS5/miR-18/miR-25 axis promotes tumorigenesis in liver cancer.
|
30191950 |
2019 |
|
| Entrez Id: |
406957 |
| Gene Symbol: |
MIR181C |
MIR181C
|
Liver neoplasms
|
0.200 |
Biomarker |
RGD |
MicroRNA‑181c suppresses growth and metastasis of hepatocellular carcinoma by modulating NCAPG.
|
31114379 |
2019 |
|
| Entrez Id: |
406900 |
| Gene Symbol: |
MIR106B |
MIR106B
|
Liver neoplasms
|
0.200 |
ModifyingMutation |
RGD |
MicroRNA-106b-5p promotes hepatocellular carcinoma development via modulating FOG2.
|
31406464 |
2019 |
|
| Entrez Id: |
841 |
| Gene Symbol: |
CASP8 |
CASP8
|
Liver neoplasms
|
0.200 |
Therapeutic |
RGD |
Chloroquine upregulates TRAIL/TRAILR2 expression and potentiates doxorubicin anti-tumor activity in thioacetamide-induced hepatocellular carcinoma model.
|
29133031 |
2018 |
|
| Entrez Id: |
406953 |
| Gene Symbol: |
MIR18A |
MIR18A
|
Liver neoplasms
|
0.200 |
ModifyingMutation |
RGD |
MicroRNA-18a promotes hepatocellular carcinoma proliferation, migration, and invasion by targeting Bcl2L10.
|
30519035 |
2018 |
|
| Entrez Id: |
842 |
| Gene Symbol: |
CASP9 |
CASP9
|
Liver neoplasms
|
0.200 |
Therapeutic |
RGD |
Chloroquine upregulates TRAIL/TRAILR2 expression and potentiates doxorubicin anti-tumor activity in thioacetamide-induced hepatocellular carcinoma model.
|
29133031 |
2018 |
|
| Entrez Id: |
406937 |
| Gene Symbol: |
MIR145 |
MIR145
|
Liver neoplasms
|
0.200 |
ModifyingMutation |
RGD |
Investigation of the clinical significance and prognostic value of microRNA-145 in human hepatocellular carcinoma.
|
30572504 |
2018 |
|
| Entrez Id: |
406953 |
| Gene Symbol: |
MIR18A |
MIR18A
|
Liver neoplasms
|
0.200 |
Biomarker |
RGD |
Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma.
|
29455432 |
2018 |
|
| Entrez Id: |
407053 |
| Gene Symbol: |
MIR96 |
MIR96
|
Liver neoplasms
|
0.200 |
Biomarker |
RGD |
miR-96 targets SOX6 and promotes proliferation, migration, and invasion of hepatocellular carcinoma.
|
28892647 |
2018 |
|
| Entrez Id: |
5428 |
| Gene Symbol: |
POLG |
POLG
|
Liver neoplasms
|
0.200 |
SusceptibilityMutation |
RGD |
Polymorphisms in POLG were associated with the prognosis and mtDNA content in hepatocellular carcinoma patients.
|
28457473 |
2017 |
|
| Entrez Id: |
406900 |
| Gene Symbol: |
MIR106B |
MIR106B
|
Liver neoplasms
|
0.200 |
ModifyingMutation |
RGD |
Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma.
|
28611524 |
2017 |
|
| Entrez Id: |
406900 |
| Gene Symbol: |
MIR106B |
MIR106B
|
Liver neoplasms
|
0.200 |
Biomarker |
RGD |
Crosstalk between liver-related microRNAs and Wnt/β-catenin pathway in hepatocellular carcinoma patients.
|
28958640 |
2017 |
|
| Entrez Id: |
407014 |
| Gene Symbol: |
MIR25 |
MIR25
|
Liver neoplasms
|
0.200 |
Biomarker |
RGD |
miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
|
27298561 |
2016 |
|
| Entrez Id: |
407053 |
| Gene Symbol: |
MIR96 |
MIR96
|
Liver neoplasms
|
0.200 |
ModifyingMutation |
RGD |
Wnt/β-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion.
|
25813403 |
2015 |
|
| Entrez Id: |
406953 |
| Gene Symbol: |
MIR18A |
MIR18A
|
Liver neoplasms
|
0.200 |
Biomarker |
RGD |
Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma.
|
24975878 |
2015 |
|
| Entrez Id: |
406900 |
| Gene Symbol: |
MIR106B |
MIR106B
|
Liver neoplasms
|
0.200 |
Biomarker |
RGD |
Plasma microRNA might as a potential biomarker for hepatocellular carcinoma and chronic liver disease screening.
|
25894380 |
2015 |
|
| Entrez Id: |
27086 |
| Gene Symbol: |
FOXP1 |
FOXP1
|
Liver neoplasms
|
0.200 |
Therapeutic |
RGD |
Molecular mechanisms of nano-selenium in mitigating hepatocellular carcinoma induced by N-nitrosodiethylamine (NDEA) in rats.
|
25156538 |
2014 |
|
| Entrez Id: |
407014 |
| Gene Symbol: |
MIR25 |
MIR25
|
Liver neoplasms
|
0.200 |
ModifyingMutation |
RGD |
Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma.
|
24593846 |
2014 |
|
| Entrez Id: |
6426 |
| Gene Symbol: |
SRSF1 |
SRSF1
|
Liver neoplasms
|
0.200 |
Biomarker |
RGD |
Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors.
|
23633480 |
2013 |
|
HNRNPA2B1
|
Liver neoplasms
|
0.200 |
Biomarker |
RGD |
Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors.
|
23633480 |
2013 |
|
| Entrez Id: |
10498 |
| Gene Symbol: |
CARM1 |
CARM1
|
Liver neoplasms
|
0.200 |
Biomarker |
RGD |
Elevated expression of coactivator-associated arginine methyltransferase 1 is associated with early hepatocarcinogenesis.
|
23912631 |
2013 |
|
| Entrez Id: |
3184 |
| Gene Symbol: |
HNRNPD |
HNRNPD
|
Liver neoplasms
|
0.200 |
Biomarker |
RGD |
Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression.
|
22318685 |
2012 |
|
| Entrez Id: |
2638 |
| Gene Symbol: |
GC |
GC
|
Liver neoplasms
|
0.200 |
Biomarker |
RGD |
Gel-based proteomics of liver cancer progression in rat.
|
21683810 |
2011 |
|
| Entrez Id: |
55607 |
| Gene Symbol: |
PPP1R9A |
PPP1R9A
|
Liver neoplasms
|
0.200 |
ModifyingMutation |
RGD |
Mitochondrial prohibitins and septin 9 are implicated in the onset of rat hepatocarcinogenesis.
|
20935162 |
2011 |